FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2081219792> ?p ?o ?g. }

• W2081219792 endingPage "897" @default.
• W2081219792 startingPage "884" @default.
• W2081219792 abstract "Culture of human peripheral blood lymphocytes (PBL) in partially purified and lectin-free interleukin 2 results in the generation of cytotoxic effector cells which have the unique property of lysing natural killer (NK)-resistant fresh human tumor cells. We have termed these effector cells lymphokine- activated killer cells (LAK). LAK are generated from both normal and cancer patients' PBL and are able to lyse both autologous and allogeneic tumor cells from all histologic tumor types tested. Our previous studies suggested that the LAK phenomenon was distinct from either the cytotoxic thymus-derived lymphocyte (CTL) or NK systems based on a variety of criteria. This study reports that the cell type involved is also distinct, as determined by phenotypic characteristics. The LAK effector cell phenotype was analyzed in parallel with alloimmune CTL, and LAK were found to be similarly susceptible to the monoclonal anti-T cell antibodies OKT-3 or OKT-8 plus complement. In contrast the LAK precursor was not susceptible to the OKT-3 or Leu-1 antibodies plus complement, while the ability to generate alloimmune CTL was totally obliterated when tested using the same PBL responder population; in fact, generation of LAK was found to be augmented five- to sixfold, clearly suggesting that LAK precursor cells are not T lymphocytes as defined by these antibodies. LAK precursors were found to be abundant in NK cell-enriched Percoll gradient fractions, which had been depleted of the 29 degrees C E- rosetting high affinity T cells. However, LAK precursors were found to be distinct from the majority of NK cells since lysis of fresh PBL with the monoclonal antibodies OKM-1, Leu-7, or OKT-11 significantly depleted or totally eliminated NK activity, while subsequent activation of the remaining cells generated high levels of LAK and in some cases augmented levels of LAK. LAK precursors were found to be distributed in the thymus, bone marrow, spleen, lymph node, and thoracic duct in addition to the PBL. Therefore, while the cell(s) responsible for activation and expression of LAK activity have some common features with the classic T cell-mediated CTL and NK cell systems, the LAK precursor cells are clearly distinct as determined by phenotype analysis using monoclonal antibodies and complement, and at present must be classified as a null cell." @default.
• W2081219792 created "2016-06-24" @default.
• W2081219792 creator A5013915121 @default.
• W2081219792 creator A5014513613 @default.
• W2081219792 creator A5029666809 @default.
• W2081219792 creator A5069637890 @default.
• W2081219792 creator A5072133376 @default.
• W2081219792 creator A5079828924 @default.
• W2081219792 date "1983-03-01" @default.
• W2081219792 modified "2023-10-14" @default.
• W2081219792 title "Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells" @default.
• W2081219792 cites W1485716528 @default.
• W2081219792 cites W1489850871 @default.
• W2081219792 cites W1504875452 @default.
• W2081219792 cites W1545419493 @default.
• W2081219792 cites W1555115566 @default.
• W2081219792 cites W1563612582 @default.
• W2081219792 cites W1564432735 @default.
• W2081219792 cites W1567106414 @default.
• W2081219792 cites W1571681582 @default.
• W2081219792 cites W1601344030 @default.
• W2081219792 cites W1633669131 @default.
• W2081219792 cites W1663122810 @default.
• W2081219792 cites W1783973309 @default.
• W2081219792 cites W1905404669 @default.
• W2081219792 cites W1980535421 @default.
• W2081219792 cites W1999237928 @default.
• W2081219792 cites W1999298353 @default.
• W2081219792 cites W2004106131 @default.
• W2081219792 cites W2019235280 @default.
• W2081219792 cites W2027922729 @default.
• W2081219792 cites W2034537357 @default.
• W2081219792 cites W2036275492 @default.
• W2081219792 cites W2046544299 @default.
• W2081219792 cites W2052439829 @default.
• W2081219792 cites W2102251060 @default.
• W2081219792 cites W2111241013 @default.
• W2081219792 cites W2141418667 @default.
• W2081219792 cites W2148278841 @default.
• W2081219792 cites W2157187560 @default.
• W2081219792 cites W2221260322 @default.
• W2081219792 cites W2412140329 @default.
• W2081219792 cites W2412519231 @default.
• W2081219792 cites W2992693023 @default.
• W2081219792 doi "https://doi.org/10.1084/jem.157.3.884" @default.
• W2081219792 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2186968" @default.
• W2081219792 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6601174" @default.
• W2081219792 hasPublicationYear "1983" @default.
• W2081219792 type Work @default.
• W2081219792 sameAs 2081219792 @default.
• W2081219792 citedByCount "460" @default.
• W2081219792 countsByYear W20812197922013 @default.
• W2081219792 countsByYear W20812197922014 @default.
• W2081219792 countsByYear W20812197922016 @default.
• W2081219792 countsByYear W20812197922018 @default.
• W2081219792 countsByYear W20812197922020 @default.
• W2081219792 countsByYear W20812197922021 @default.
• W2081219792 countsByYear W20812197922022 @default.
• W2081219792 crossrefType "journal-article" @default.
• W2081219792 hasAuthorship W2081219792A5013915121 @default.
• W2081219792 hasAuthorship W2081219792A5014513613 @default.
• W2081219792 hasAuthorship W2081219792A5029666809 @default.
• W2081219792 hasAuthorship W2081219792A5069637890 @default.
• W2081219792 hasAuthorship W2081219792A5072133376 @default.
• W2081219792 hasAuthorship W2081219792A5079828924 @default.
• W2081219792 hasBestOaLocation W20812197921 @default.
• W2081219792 hasConcept C129374314 @default.
• W2081219792 hasConcept C139563560 @default.
• W2081219792 hasConcept C147969180 @default.
• W2081219792 hasConcept C153911025 @default.
• W2081219792 hasConcept C154317977 @default.
• W2081219792 hasConcept C159654299 @default.
• W2081219792 hasConcept C202751555 @default.
• W2081219792 hasConcept C203014093 @default.
• W2081219792 hasConcept C206191192 @default.
• W2081219792 hasConcept C2776090121 @default.
• W2081219792 hasConcept C2777371288 @default.
• W2081219792 hasConcept C2778102761 @default.
• W2081219792 hasConcept C28651165 @default.
• W2081219792 hasConcept C2908647359 @default.
• W2081219792 hasConcept C49382859 @default.
• W2081219792 hasConcept C542903549 @default.
• W2081219792 hasConcept C55493867 @default.
• W2081219792 hasConcept C71924100 @default.
• W2081219792 hasConcept C86803240 @default.
• W2081219792 hasConcept C8891405 @default.
• W2081219792 hasConcept C99454951 @default.
• W2081219792 hasConceptScore W2081219792C129374314 @default.
• W2081219792 hasConceptScore W2081219792C139563560 @default.
• W2081219792 hasConceptScore W2081219792C147969180 @default.
• W2081219792 hasConceptScore W2081219792C153911025 @default.
• W2081219792 hasConceptScore W2081219792C154317977 @default.
• W2081219792 hasConceptScore W2081219792C159654299 @default.
• W2081219792 hasConceptScore W2081219792C202751555 @default.
• W2081219792 hasConceptScore W2081219792C203014093 @default.
• W2081219792 hasConceptScore W2081219792C206191192 @default.
• W2081219792 hasConceptScore W2081219792C2776090121 @default.
• W2081219792 hasConceptScore W2081219792C2777371288 @default.

• next